Company profile NEXI

Neximmune Inc
neximmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary aim™ technology. this nanotechnology platform, originally developed at johns hopkins university, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted t cell response a...gainst a disease. central to the aim technology are artificial antigen presenting cells (aapc) that present antigens to t cells eliciting a highly targeted therapy driven by the patient’s immune system. these aapc can be rapidly engineered to elicit a specific immune attack that can be directed toward any foreign substance or cell type in a patient’s body. Show More
Quarter analysis & expected interestLast update: February 09 2024 03:39:46.

After 39 days of this quarter the interest is at 72.0. Based on that we can calculate that during remaining 52 days it will total up to 168.0.
NexImmune expected interest is significantly higher compared to same quarter last year (+76.8%) but similar to previous quarter.

YearQ1Q2Q3Q4
201930
72
140.0% QoQ
47
-34.7% QoQ
84
78.7% QoQ
2020 33
10.0% YoY -60.7% QoQ
144
100.0% YoY 336.4% QoQ
56
19.1% YoY -61.1% QoQ
86
2.4% YoY 53.6% QoQ
2021 322
875.8% YoY 274.4% QoQ
298
106.9% YoY -7.5% QoQ
182
225.0% YoY -38.9% QoQ
111
29.1% YoY -39.0% QoQ
2022 280
-13.0% YoY 152.3% QoQ
208
-30.2% YoY -25.7% QoQ
142
-22.0% YoY -31.7% QoQ
184
65.8% YoY 29.6% QoQ
2023 95
-66.1% YoY -48.4% QoQ
133
-36.1% YoY 40.0% QoQ
152
7.0% YoY 14.3% QoQ
263
42.9% YoY 73.0% QoQ
2024 72
-24.2% YoY -72.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NexImmune search interestLast update: February 09 2024 03:39:45.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 03:39:47.

The average 5 years interest of NexImmune was 11.47 per week.
The last year interest of NexImmune compared to the last 5 years has changed by 8.98%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 167.67%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 03:37:28.

After 34 days of this quarter the interest is at 122.0. Based on that we can calculate that during remaining 58 days it will total up to 330.0.
NexImmune expected interest is significantly higher compared to previous quarter (+79.3%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 78
2019 158
102.6% QoQ
34
-78.5% QoQ
178
423.5% QoQ
144
84.6% YoY -19.1% QoQ
2020 101
-36.1% YoY -29.9% QoQ
67
97.1% YoY -33.7% QoQ
16
-91.0% YoY -76.1% QoQ
0
-100.0% YoY -100.0% QoQ
2021 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2022 144
inf% YoY inf% QoQ
225
inf% YoY 56.2% QoQ
137
inf% YoY -39.1% QoQ
254
inf% YoY 85.4% QoQ
2023 141
-2.1% YoY -44.5% QoQ
282
25.3% YoY 100.0% QoQ
184
34.3% YoY -34.8% QoQ
122
-52.0% YoY -33.7% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NexImmune search interestLast update: November 06 2023 03:37:28.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 03:37:29.

The average 5 years interest of NexImmune was 8.71 per week.
The last year interest of NexImmune compared to the last 5 years has changed by 95.64%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 78.62%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune company to provide analysis

Correlation between past revenue and NexImmune company search interest

There is not enough data for NexImmune company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 03:39:59.

After 39 days of this quarter the interest is at 133.0. Based on that we can calculate that during remaining 52 days it will total up to 310.0.
NexImmune stock expected interest is significantly higher compared to same quarter last year (+507.8%) but similar to previous quarter.

YearQ1Q2Q3Q4
201939
99
153.8% QoQ
137
38.4% QoQ
58
-57.7% QoQ
2020 21
-46.2% YoY -63.8% QoQ
51
-48.5% YoY 142.9% QoQ
47
-65.7% YoY -7.8% QoQ
110
89.7% YoY 134.0% QoQ
2021 334
1490.5% YoY 203.6% QoQ
193
278.4% YoY -42.2% QoQ
199
323.4% YoY 3.1% QoQ
114
3.6% YoY -42.7% QoQ
2022 103
-69.2% YoY -9.6% QoQ
145
-24.9% YoY 40.8% QoQ
176
-11.6% YoY 21.4% QoQ
34
-70.2% YoY -80.7% QoQ
2023 51
-50.5% YoY 50.0% QoQ
56
-61.4% YoY 9.8% QoQ
98
-44.3% YoY 75.0% QoQ
226
564.7% YoY 130.6% QoQ
2024 133
160.8% YoY -41.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NexImmune stock search interestLast update: February 09 2024 03:39:57.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 03:40:02.

The average 5 years interest of NexImmune stock was 9.29 per week.
The last year interest of NexImmune stock compared to the last 5 years has changed by 13.24%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 54.48%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune news to provide analysis

Correlation between past revenue and NexImmune news search interest

There is not enough data for NexImmune news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune cancer therapy to provide analysis

Correlation between past revenue and NexImmune cancer therapy search interest

There is not enough data for NexImmune cancer therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune cancer therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune clinical trials to provide analysis

Correlation between past revenue and NexImmune clinical trials search interest

There is not enough data for NexImmune clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune immunotherapy to provide analysis

Correlation between past revenue and NexImmune immunotherapy search interest

There is not enough data for NexImmune immunotherapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune immunotherapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune nanoparticle technology to provide analysis

Correlation between past revenue and NexImmune nanoparticle technology search interest

There is not enough data for NexImmune nanoparticle technology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune nanoparticle technology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NexImmune Gaithersburg location to provide analysis

Correlation between past revenue and NexImmune Gaithersburg location search interest

There is not enough data for NexImmune Gaithersburg location to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NexImmune Gaithersburg location to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for NEXI
Earnings date: 2024-03-26 After close
Company name: Neximmune Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-09-06T07:41:13-04:00

SEC
25-NSE Form - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - NexImmune, Inc. (0001538210) (Subject)

2024-08-29T00:15:04-04:00

SEC
EFFECT Form - Notice of Effectiveness - NexImmune, Inc. (0001538210) (Filer)

2024-08-27T16:10:49-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - NexImmune, Inc. (0001538210) (Filer)

2024-08-27T16:08:55-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - NexImmune, Inc. (0001538210) (Filer)

2024-08-27T16:06:49-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - NexImmune, Inc. (0001538210) (Filer)

2024-08-27T16:03:28-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - NexImmune, Inc. (0001538210) (Filer)

2024-08-27T16:01:53-04:00

SEC
8-K Form - Current report, items 5.02 and 8.01 - NexImmune, Inc. (0001538210) (Filer)

2024-08-15T16:02:00-04:00

SEC
8-K Form - Current report, item 5.07 - NexImmune, Inc. (0001538210) (Filer)

2024-08-07T16:05:47-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - NexImmune, Inc. (0001538210) (Filer)

2024-08-02T16:05:57-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - NexImmune, Inc. (0001538210) (Filer)

2024-08-02T16:03:53-04:00

SEC
8-K Form - Current report, items 5.07 and 8.01 - NexImmune, Inc. (0001538210) (Filer)

2024-07-19T16:03:56-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - NexImmune, Inc. (0001538210) (Filer)

2024-07-19T16:01:31-04:00

SEC
8-K Form - Current report, items 5.07 and 8.01 - NexImmune, Inc. (0001538210) (Filer)

2024-07-11T15:12:55-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - NexImmune, Inc. (0001538210) (Filer)

2024-07-11T15:10:33-04:00

SEC
8-K Form - Current report, items 3.01, 5.07, and 8.01 - NexImmune, Inc. (0001538210) (Filer)